Athena Countouriotis, President & CEO at Turning Point Therapeutics, Inc. (TPTX), sold 5,942 shares at $36.30 ($216K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $216k TPTX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.30 | 2,971 | $108K | 50.0% |
| 2 | $36.30 | 2,971 | $108K | 50.0% |
| Total | $36.30 avg | 5,942 | $216K | 100% |
| Filing → |
| PASG | BUY | 2020-03-25 | $150K | — | Filing → |
| PASG | BUY | 2020-03-03 | $160K | — | Filing → |
| TPTX | BUY | 2019-09-11 | $450K | — | Filing → |